Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/72993
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-04-06T10:42:09Z-
dc.date.available2021-04-06T10:42:09Z-
dc.date.issued2018-
dc.identifier.citationSciortino, M. (2018). A mixed integer programming problem in the pharmaceutical industry (Master's dissertation).en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/72993-
dc.descriptionM.SC.OP.RESEARCHen_GB
dc.description.abstractThis dissertation deals with an optimization problem which appears in the context of scheduling pharmaceutical quality control tests. Scheduling such tests, which are mandatory to approve the safety, purity and efficacy of pharmaceutical product families, is a very challenging task given the limited resource availability and the fact that a single product family must undergo multiple tests. The aim of this study is to develop an original mixed integer linear programming (MILP) model for scheduling these laboratory tests within the pharmaceutical company Aurobindo Pharma (Malta) Limited. Each week the company needs to plan tests for approximately 40 different product families, with each family requiring at least 5 different tests. Effective plans are thus essential for increasing efficiency of the laboratory and improving utilization of resources (employees/machines). The proposed model determines a schedule over a given planning horizon by minimizing the makespan. It encompasses constraints such as assignment constraints of different stages of tests to resources and timing constraints between tests pertaining to the same product family. Having formulated the model, theoretical background on the existence and uniqueness of optimal solutions to MILP problems is studied and exemplified. The proposed model has been implemented in GAMS and solved by CPLEX/GUROBI via a Branch-and-Cut solution approach. Computational experiments were run on real data provided by the company over different planning horizons. The success of obtained results is reported via Gantt charts.en_GB
dc.language.isoenen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectPharmaceutical industry -- Malta -- Linear programmingen_GB
dc.subjectInteger programmingen_GB
dc.titleA mixed integer programming problem in the pharmaceutical industryen_GB
dc.typemasterThesisen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Science. Department of Statistics and Operations Researchen_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorSciortino, Monique (2018)-
Appears in Collections:Dissertations - FacSci - 2018
Dissertations - FacSciSOR - 2018

Files in This Item:
File Description SizeFormat 
18MSCOR001.pdf
  Restricted Access
30.25 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.